Abstracts of AGM & Clinical Meeting on 12-July-2002

Index of Abstracts

  1. MRC Myeloma VII - Dr Tony Child
  2. MRC Myeloma VIII - Dr Tony Child
  3. UKMF Pilot Study: The Mini-allograft Trial - Dr Cathy Williams
  4. UKMF Pilot Study: MPT - Dr Heather Oakervee & Dr Jamie Cavenagh
  5. UKMF Pilot Study: T-VAD - Dr Heather Oakervee & Dr Jamie Cavenagh
  6. Thalidomide Maintenance Following High Dose Therapy In Multiple Myeloma - Dr Rod Johnson & Dr Graham Jackson
  7. Cytogenetics in Myeloma - Dr Fiona Ross
  8. MRC Myeloma IX - Dr Tony Child
  9. Pilot Survey Of Younger Myeloma Patients Not Undergoing Blood or Marrow Transplantation - TCM (Curly) Morris
  10. MERIT trial - Dr Judith Behrens
  11. Forthcoming Phase II/III Studies Of PS-341 In Multiple Myeloma - Dr Jamie Cavenagh
  12. A Phase I Study Of An Immunomodulatory Drug (CC 4047) - Dr Steve Schey
  13. Phase I/II Study of Arsenic Trioxide in Patients with Multiple Myeloma - Dr Steve Schey
  14. UKMF Guidelines Group Report 2001-2002 - Dr Alastair Smith

Meeting organised by The UK Myeloma Forum [Registered Charity Number 1082702].

Officers

Chair: Dr Diana Samson, Hammersmith Hospital, London

Secretary: Dr Steve Schey, Guy's Hospital, London

Treasurer: Dr Charles Singer (to 12th July 2002), Royal United Hospital, Bath; Dr Graham Jackson (from 12th July 2002) Royal Victoria Infirmary, Newcastle

Chairman Clinical Trials Working Party: Dr Tony Child, Leeds General Infirmary, Leeds

Chairman Guidelines Working Party: Dr Alastair Smith, Southampton General Infirmary, Southampton

Chairman Scientific Working Party: Prof Gareth Morgan, Leeds General Infirmary, Leeds

Committee members:
Dr Jamie Cavenagh, Dr Graham Jackson (to 12th July 2002)
Prof Nigel Russell (to 12th July 2002), Dr TCM (Curly) Morris (from 12th July 2002)
Dr Catherine Williams (from 12th July 2002)

Administrator: Richard W Jones

Registered Address: Clinical Trials Office, Dept of Haematology, Guy's Hospital, London SE1 9RT. Tel: 020 7955 2031. Fax: 020 7955 2437 / 4002

Acknowledgements

The UK Myeloma Forum gratefully acknowledges the support given by the following companies / organisations towards it's work:

 

 

<< Abstracts Index

While the advice and information on this website are believed to be true and accurate at the time of publication, neither the authors, nor the UKMF accept any legal responsibility for their content.